<- Go Home

Tecan Group AG

Tecan Group AG provides laboratory instruments and solutions in biopharmaceuticals, forensics, and clinical diagnostics in Europe, North America, Asia, and internationally. It operates in two segments, Life Sciences Business and Partnering Business. The company offers liquid handling and automation, microplate readers and washers, software, consumables, NGS reagents, immunoassays and antibodies, and Tecan Labwerx, an end-to-end automation solution. It also provides PARAMIT, a contract design and manufacturing service; Synergence, a customized OEM system; Cavro, a standard and customized OEM component; and onsite and depot repairs, as well as remote services and digital solutions. The company was founded in 1980 and is headquartered in Männedorf, Switzerland.

Market Cap

CHF 1.8B

Volume

50.1K

Cash and Equivalents

CHF 255.7M

EBITDA

CHF 104.5M

Tax Rate Collected

N/A

Tax Rate Ratio

N/A

Gross Profit

CHF 319.0M

Profit Margin

35.19%

52 Week High

CHF 248.00

52 Week Low

CHF 131.50

Dividend

2.17%

Price / Book Value

1.37

Price / Earnings

27.96

Price / Tangible Book Value

5.20

Enterprise Value

CHF 1.7B

Enterprise Value / EBITDA

14.35

Operating Income

CHF 66.9M

Return on Equity

4.70%

Return on Assets

2.06

Cash and Short Term Investments

CHF 397.0M

Debt

CHF 322.0M

Equity

CHF 1.3B

Revenue

CHF 906.6M

Unlevered FCF

CHF 119.8M

Sector

Life Sciences Tools and Services

Category

N/A

Hedge Funds that own this stock

PREMIUM

Upgrade to Yellowbrick Premium to unlock the Professional Funds that own this company (and many other perks).

Upgrade to Yellowbrick Premium

Yellowbrick Portfolios that own this stock

PREMIUM

Upgrade to Yellowbrick Premium to unlock the Yellowbrick portfolios that own this company (and many other perks).

Upgrade to Yellowbrick Premium

Company Stock Pitches